XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF NET INCOME - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 26, 2020
Sep. 28, 2019
Sep. 26, 2020
Sep. 28, 2019
Income Statement [Abstract]        
Net sales $ 391,566 $ 361,971 $ 1,044,999 $ 1,165,350
Cost of sales 253,390 231,025 684,012 737,368
Gross profit 138,176 130,946 360,987 427,982
Selling, general, and administrative expenses 50,465 54,224 158,832 174,845
Goodwill impairment charge 0 0 33,841 0
Research and development expenses 13,049 19,728 41,044 62,595
Amortization of intangibles 10,104 9,827 29,912 30,068
Total operating expenses 73,618 83,779 263,629 267,508
Operating income 64,558 47,167 97,358 160,474
Interest expense 4,988 5,559 16,261 16,834
Foreign exchange (gain) loss (6,174) 4,968 (9,600) 5,636
Other income, net (1,682) (4,764) (1,643) (3,406)
Income before income taxes 67,426 41,404 92,340 141,410
Income taxes 12,070 5,757 21,331 24,982
Net income $ 55,356 $ 35,647 $ 71,009 $ 116,428
Income per share:        
Basic (in dollars per share) $ 2.27 $ 1.46 $ 2.92 $ 4.72
Diluted (in dollars per share) $ 2.25 $ 1.44 $ 2.89 $ 4.68
Weighted-average shares and equivalent shares outstanding:        
Basic (in shares) 24,357 24,482 24,354 24,646
Diluted (in shares) 24,573 24,684 24,535 24,894